ProfoundBio Company Overview, Contact Details & Competitors

Q: What is ProfoundBio's official website and social media links?

ProfoundBio's official website is genmab.com. ProfoundBio has social profiles on LinkedIn.

Q: How many employees does ProfoundBio have currently?

ProfoundBio has approximately 51 employees.

Q: What technology does ProfoundBio use?

ProfoundBio's tech stack includes Java, GraphPad Prism, Adobe ColdFusion, Splunk, Telerik Sitefinity.

Insights

Gathering insights about ProfoundBio…

Similar companies to ProfoundBio

ProfoundBio Tech Stack

ProfoundBio uses 8 technology products and services including Agilent, Informatica, AMP, and more. Explore ProfoundBio's tech stack below.

Agilent
Data Management
Informatica
Enterprise
AMP
Javascript Frameworks
PyTorch
Machine Learning
Salesforce Marketing Cloud
Marketing Performance Measurement
Smartsheet
Project Management
Datadog
Real User Monitoring
Kibana
Visualisation Software

Media & News

Genmab hired Séverine Lemoine as General Manager for France on Dec 2nd '25.
Genmab A/S (Nasdaq: GMAB) today announced the appointment of Séverine Lemoine as General Manager for France.
Dec 02, 2025 | ir.genmab.com
Genmab attended event 67th Annual Meeting on Nov 3rd '25.
Genmab A/S (Nasdaq: GMAB) today announced that more than 20 abstracts evaluating epcoritamab-bysp, a T-cell engaging bispecific antibody administered subcutaneously, across lines of therapy and B-cell non-Hodgkin's lymphoma (NHL) subtypes, will be presented at the 67th Annual Meeting and Exposition of the American Society of Hematology (ASH), in Orlando, Florida, and online, December 6-9.
Nov 03, 2025 | ir.genmab.com
Genmab will launch Merus drug candidate on Jan 1st '27.
Genmab expects to launch Merus' drug candidate for head and neck cancer, known as petosemtamab, in 2027.
Sep 29, 2025 | medwatch.com
Genmab is planning to acquire Merus B.V for $8B.
Genmab has agreed to acquire Netherlands-based biotech Merus for approximately $8 billion, giving it rights to late-stage breakthrough cancer therapy petosemtamab.
Sep 29, 2025 | www.europeanpharmaceuticalreview.com
Genmab hired Matt Kiely as General Manager for the United Kingdom on Sep 1st '25.
Genmab A/S (Nasdaq: GMAB) today announced the appointment of Matt Kiely as the General Manager for the United Kingdom as the company expands its presence in Europe to bring its innovative antibody-based medicines to more patients with cancer.
Sep 01, 2025 | ir.genmab.com
Genmab attended event Morgan Stanley 23rd Annual Global Healthcare Conference on Sep 9th '25.
Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan Van de Winkel and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York City, NY at 7:45 AM EDT (1:45 PM CEST) on September 9, 2025.
Aug 26, 2025 | ir.genmab.com
Genmab hired Katja Nielsen as General Manager for Germany on Aug 1st '25.
Genmab A/S (Nasdaq: GMAB) today announced the appointment of Dr. Katja Nielsen as the General Manager for Germany as the company strengthens its commercialization capabilities in Europe and prepares to bring its innovative antibody-based medicines to more patients.
Aug 01, 2025 | ir.genmab.com

ProfoundBio's Email Address Formats

ProfoundBio uses at least 2 format(s):

ProfoundBio Email Formats	Example	Percentage
First.Last@profoundbio.com	John.Doe@profoundbio.com	74%
FLast@profoundbio.com	JDoe@profoundbio.com	26%
F.Last@genmab.com	J.Doe@genmab.com	54%
LastFirst@genmab.com	DoeJohn@genmab.com	27%
FirstL@genmab.com	JohnD@genmab.com	13%
FiLast@genmab.com	JoDoe@genmab.com	6%

Frequently Asked Questions

What is ProfoundBio's official website and social media links?

ProfoundBio's official website is genmab.com and has social profiles on LinkedIn Crunchbase.

How much revenue does ProfoundBio generate?

As of December 2025, ProfoundBio's annual revenue is estimated to be $4.2M.

What is ProfoundBio's SIC code NAICS code?

ProfoundBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ProfoundBio have currently?

As of December 2025, ProfoundBio has approximately 51 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Senior Clinical Trial Manager: X. N.. Explore ProfoundBio's employee directory with LeadIQ.

What industry does ProfoundBio belong to?

ProfoundBio operates in the Biotechnology Research industry.

What technology does ProfoundBio use?

ProfoundBio's tech stack includes AgilentInformaticaAMPPyTorchSalesforce Marketing CloudSmartsheetDatadogKibana.

What is ProfoundBio's email format?

ProfoundBio's email format typically follows the pattern of First.Last@profoundbio.com. Find more ProfoundBio email formats with LeadIQ.

How much funding has ProfoundBio raised to date?

As of December 2025, ProfoundBio has raised $112M in funding. The last funding round occurred on Feb 13, 2024 for $112M.

Insights

Similar companies to ProfoundBio

Lonza Group

QIAGEN

Bio-Rad Laboratories

New England Biolabs

Sartorius

Abcam

Bio-Techne

Thermo Fisher Scientific

Agilent Technologies

Illumina

PerkinElmer, Inc.

Promega Corporation

ProfoundBio Tech Stack

Media & News

Genmab hired Séverine Lemoine as General Manager for France on Dec 2nd '25.

Genmab attended event 67th Annual Meeting on Nov 3rd '25.

Genmab will launch Merus drug candidate on Jan 1st '27.

Genmab is planning to acquire Merus B.V for $8B.

Genmab hired Matt Kiely as General Manager for the United Kingdom on Sep 1st '25.

Genmab attended event Morgan Stanley 23rd Annual Global Healthcare Conference on Sep 9th '25.

Genmab hired Katja Nielsen as General Manager for Germany on Aug 1st '25.

ProfoundBio's Email Address Formats

Frequently Asked Questions

What is ProfoundBio's official website and social media links?

How much revenue does ProfoundBio generate?

What is ProfoundBio's SIC code NAICS code?

How many employees does ProfoundBio have currently?

What industry does ProfoundBio belong to?

What technology does ProfoundBio use?

What is ProfoundBio's email format?

How much funding has ProfoundBio raised to date?

ProfoundBio

Company Overview

Media & News

Genmab hired Séverine Lemoine as General Manager for France on Dec 2nd '25.

Genmab attended event 67th Annual Meeting on Nov 3rd '25.

Genmab will launch Merus drug candidate on Jan 1st '27.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?